Cancer HealthCast: NCI Program Unlocks Emerging Proteomic Data to Advance Precision Medicine
Researchers say sharing molecular cancer research data can expand cancer treatment and care.
Proteomics is an emerging field in cancer care and research. The National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) aims to get to the heart of cancer by studying its molecular basis across different cancers. The group believes expanding open-source resources and other data can lead to new treatments in cancer and expand precision medicine.
Dr. Henry Rodriguez, the founding director of the Office of Cancer Clinical Proteomics Research at NCI, discusses the program and how the related International Cancer Proteogenome Consortium (ICPC) is helping researchers pull together resources necessary to innovate cancer care.
-
Dr. Henry Rodriguez Founding Director, Office of Cancer Clinical Proteomics Research NCI
-
Army's Project Gatekeeper Platform to Launch This Month
Acting Army CIO Gabe Chiulli said the service’s new DevSecOps platform designed to more efficiently engage industry will debut on Oct. 23.
3m read -
AI Adoption Pushes Agencies to Rethink Infrastructure, Costs
Federal technology leaders are prioritizing flexible infrastructure, cost management and human oversight as AI takes on more complex tasks.
3m read -
Keeping Aging Federal Systems Running Amid OT Vulnerabilities
A techno-thriller novel highlights how organizational silos can become critical infrastructure vulnerabilities in the AI era.
19m watch -
NASA, CBP Tackle Data Access, Security Challenges Amid AI Expansion
NASA and CBP data leaders discuss how their agencies are balancing data accessibility, security and governance to advance AI capabilities.
2m read
